E88.82 Código facturable y específico Obesity due to disruption of MC4R pathway

ICD-10-CM E88.82 identifies “Obesity due to disruption of MC4R pathway” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Capítulo 4: Endocrine, nutritional and metabolic diseases

Instrucciones del código

Use additional code2
  • code, if applicable, to identify associated manifestations, such as polyphagia (R63.2)
  • code to identify body mass index (BMI), if known (Z68.-)

Instrucciones de niveles superiores

E88 · Other and unspecified metabolic disorders

Excludes 11

histiocytosis X (chronic) (C96.6)

Use additional code1

codes for associated conditions

Capítulos 4 · Endocrine, nutritional and metabolic diseases (E00-E89)

Excludes 11

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note1

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

E70-E88 · Metabolic disorders (E70-E88)

Excludes 15
  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)
Excludes 21

Ehlers-Danlos syndromes (Q79.6-)

Referencias del índice oficial

Referencias del índice oficial (8)

Obesity (8)

Historial oficial de conversión

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Fechas de vigencia 2024-10-01

Asignación anterior: E88.89

Historial

Historial del código

Último cambio registrado · FY2025

ModificadoSin cambios
FY2025

Vigente desde

  • Añadido

Obesity due to disruption of MC4R pathway

Código de diagnóstico facturable

CDC/NCHS · FY2025

Todas las ediciones (5)

Todas las edicionesVigente desdeHistorial del código
FY20252024-10-01Añadido
FY2025 · 04-012025-04-01Sin cambios tabulares
FY20262025-10-01Sin cambios tabulares
FY2026 · April2026-04-01Sin cambios tabulares
FY20272026-10-01Sin cambios tabulares

Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.